Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CP.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EQ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EQ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.75.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.12ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used